| Dr Rodrigo Brito Erlich, MD | |
|
1000 4th St Sw, Mason City, IA 50401-2800 | |
| (641) 428-7000 | |
| (641) 428-6347 |
| Full Name | Dr Rodrigo Brito Erlich |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 38 Years |
| Location | 1000 4th St Sw, Mason City, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720039126 | NPI | - | NPPES |
| 628402700 | Medicaid | MD | |
| CA8374 | Other | MD | R/R MEDICARE GROUP # |
| P00035912 | Other | MD | R/R MEDICARE PROVIDER # |
| Facility Name | Location | Facility Type |
|---|---|---|
| Genesis Hospital | Zanesville, OH | Hospital |
| Lima Memorial Health System | Lima, OH | Hospital |
| Sanford Bemidji Medical Center | Bemidji, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Genesis Medical Group, Llc | 7719040385 | 218 |
News Archive
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc. has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Ibandronate 150mg tablets, the generic equivalent to Roche's BONIVA tablets.
› Verified 3 days ago
| Entity Name | Genesis Medical Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063663433 PECOS PAC ID: 7719040385 Enrollment ID: O20090107000547 |
News Archive
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc. has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Ibandronate 150mg tablets, the generic equivalent to Roche's BONIVA tablets.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rodrigo Brito Erlich, MD 2575 Northwinds Pkwy, Alpharetta, GA 30009-2232 Ph: () - | Dr Rodrigo Brito Erlich, MD 1000 4th St Sw, Mason City, IA 50401-2800 Ph: (641) 428-7000 |
News Archive
Almost a quarter of colorectal (bowel) cancer cases could be prevented if people followed healthy lifestyle advice in five areas including diet and exercise, says a new study published on bmj.com today.
Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 1b study designed to evaluate the safety of MP4CO treatment in patients with sickle cell disease.
More and more strains of bacteria are developing resistance to previously life-saving antibiotics. Researchers at TUM, the Technische Universitaet Muenchen, have shed light on a metabolic step that appears in many aggressive microorganisms - such as tuberculosis and malaria pathogens - and that may provide a promising target for a new class of antibiotics. The researchers present their results in the chemistry journal Angewandte Chemie.
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc. has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for Ibandronate 150mg tablets, the generic equivalent to Roche's BONIVA tablets.
› Verified 3 days ago
Burt Humburg, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-7000 Fax: 641-428-6383 | |
Sumathy Nagraj Iyengar, M.D., Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mercy Medical Center-hospitalist Dept, Mason City, IA 50401 Phone: 641-428-7000 | |
Mark C Johnson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 910 N Eisenhower Ave, Mason City, IA 50401 Phone: 641-428-7799 Fax: 641-428-5274 | |
Dr. Joseph Dean Mccracken, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1000 4th St Sw, Mason City, IA 50401 Phone: 641-428-6300 Fax: 641-428-6347 | |
Nathaniel Hitt, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 621 S Illinois Ave Ste 100, Mason City, IA 50401 Phone: 641-428-6900 Fax: 641-428-3909 | |
Dr. Byron T Beasley, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5300 Fax: 641-494-5329 | |
Radu Hagau, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 250 S Crescent Dr, Mason City, IA 50401 Phone: 641-494-5300 Fax: 641-494-5321 |